Advertisement
Actualités Forex
Dollar Loses Ground Against Major Counterparts
The U.S. dollar shed ground against its major counterparts on Wednesday, retreating after rising sharply in the previous session amid bets on aggressive rate hike by the Fed after data showed a rise in consumer price inflation.
RTTNews |
il y a 957
Swiss Market Ends Lower Again
The Switzerland stock market ended notably lower for a second straight day as worries about rising inflation and looming interest rate hikes triggered a sell-off on Wednesday.
RTTNews
|
il y a 957
European Stocks Close Lower Again On Concerns Over Inflation, Slowing Growth
European stocks closed notably lower on Wednesday as investors continued to react to Wednesday's report from the U.S. Labor Department showing hotter-than-expected consumer prices inflation in the world's largest economy.
RTTNews
|
il y a 957
Canadian Market Up In Positive Territory As Energy Stocks Rally
The Canadian market is up firmly in positive territory a little past noon on Wednesday, with stocks from energy sector rallying sharply, tracking higher crude oil prices.
RTTNews
|
il y a 957
Japanese Yen Rebounds As BoJ Signals Forex Intervention
The Japanese yen erased its early losses against its major counterparts in the European session on Wednesday, after reports of a rate check by the Bank of Japan, which could be interpreted as a preparation to intervene in the forex market to boost the battered currency.
RTTNews
|
il y a 958
U.S. Producer Prices Edge Lower In August, Annual Growth Slows Notably
Reflecting another sharp decline in energy prices, the Labor Department released a report on Wednesday showing a modest decrease in U.S. producer prices in the month of August.
RTTNews
|
il y a 958
EFFECTOR Says First Patient Dosed In Second Cohort Of Phase 1b Trial Of Zotatifin For COVID-19
Biopharmaceutical company eFFECTOR Therapeutics, Inc. (EFTR) announced Wednesday it has dosed the first patient in the second cohort of its Phase 1b clinical trial of zotatifin in non-hospitalized adults with confirmed COVID-19 infection.
RTTNews
|
il y a 958
more news
U.S. Producer Prices Edge Down In Line With Estimates In August
Reflecting another sharp decline in energy prices, the Labor Department released a report on Wednesday showing a modest decrease in U.S. producer prices in the month of August.
RTTNews
|
il y a 958
Tabula Rasa HealthCare Co-Founders Calvin Knowlton And Orsula Knowlton To Retire
Healthcare technology company Tabula Rasa HealthCare, Inc. (TRHC) announced Wednesday that co-founders Calvin Knowlton, Chief Executive Officer and Board Chairman, and Orsula Knowlton, Co-President and Chief Marketing and New Business Development Officer, will retire from the company and step down as members of the Board of Directors, effective immediately.
RTTNews
|
il y a 958
Trimble Acquires B2W Software For Undisclosed Terms
Technology company Trimble, Inc. (TRMB) announced Wednesday it has acquired privately-held B2W Software, a leading provider of estimating and operations solutions for the heavy civil construction industry. Financial terms were not disclosed.
RTTNews
|
il y a 958
Bay Street Likely To Open On Mixed Note
Canadian shares are likely to open on a mixed note on Wednesday, tracking sluggish commodity prices and slightly higher U.S. futures.
RTTNews
|
il y a 958
Lavie Bio Appoints Guri Oron As CEO
Lavie Bio Ltd., a subsidiary of Evogene Ltd. (EVGN), announced Wednesday the appointment of Guri Oron as Chief Executive Officer of Lavie Bio, effective as of September 18, 2022.
RTTNews
|
il y a 958
Pfizer Doses First Participants In Phase 3 Study Of MRNA-Based Influenza Vaccine
Drug major Pfizer Inc. (PFE) announced Wednesday that the first participants have been dosed in a pivotal Phase 3 clinical trial to evaluate the efficacy, safety, tolerability and immunogenicity of the company's quadrivalent modified RNA (modRNA) influenza vaccine candidate. The study will enrol approximately 25,000 healthy U.S. adults 18 years and older.
RTTNews
|
il y a 958
Stay up to date!
Add Actualités to your browser
Add To Chrome
